These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 20568411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Management of systemic sclerosis.
    Lim IG, Schrieber L.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):953-7. PubMed ID: 12455189
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment Algorithms for Systemic Sclerosis According to Experts.
    Fernández-Codina A, Walker KM, Pope JE, Scleroderma Algorithm Group.
    Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
    [Abstract] [Full Text] [Related]

  • 5. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M, EUSTAR Co-Authors.
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [Abstract] [Full Text] [Related]

  • 6. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M, Varga J.
    Am Fam Physician; 2008 Oct 15; 78(8):961-8. PubMed ID: 18953973
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.
    Nagaraja V, Matucci-Cerinic M, Furst DE, Kuwana M, Allanore Y, Denton CP, Raghu G, Mclaughlin V, Rao PS, Seibold JR, Pauling JD, Whitfield ML, Khanna D.
    Arthritis Rheumatol; 2020 Jul 15; 72(7):1049-1058. PubMed ID: 32134199
    [Abstract] [Full Text] [Related]

  • 12. [Lung involvement in systemic sclerosis].
    Posa M, Stelle M, Lador F, Chizzolini C.
    Rev Med Suisse; 2015 Apr 08; 11(469):802-6. PubMed ID: 26040160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular disease in systemic sclerosis.
    Poredos P.
    Vasa; 2011 Jan 08; 40(1):3-4. PubMed ID: 21375075
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current treatment options in systemic Sclerosis (Scleroderma).
    Stummvoll GH.
    Acta Med Austriaca; 2002 Jan 08; 29(1):14-9. PubMed ID: 11899748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Pope J, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research Group, Baron M.
    J Rheumatol; 2012 Mar 08; 39(3):524-31. PubMed ID: 22247347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.